Published in J Natl Cancer Inst on July 03, 1991
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer (2010) 2.25
Metastatic pleomorphic sarcoma to left atrium. Rare Tumors (2009) 0.95
Anthracyclines: cardiotoxicity and its prevention. Arch Dis Child (1994) 0.85
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy. Clin Epigenetics (2015) 0.85
Management of chemotherapy induced cardiomyopathy. Curr Cardiol Rev (2011) 0.83
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours. Br J Cancer (2006) 0.79
Primary leiomyosarcoma of gallbladder. J Korean Surg Soc (2012) 0.79
Multimodality therapy for metastatic sarcomas confined to the lung. Oncol Lett (2012) 0.77
Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case. Surg Today (2006) 0.76
Doxorubicin and Dacarbazine (AD) Regimen for Soft Tissue Sarcomas. Hosp Pharm (2015) 0.75
Schedule-dependent topoisomerase II-inhibiting drugs. Cancer Chemother Pharmacol (1994) 0.75
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin (1982) 4.90
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol (2001) 4.73
Evaluation of cancer information on the Internet. Cancer (1999) 4.55
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem (1992) 3.64
Outpatient PTCA with same day discharge is safe and produces high patient satisfaction level. J Invasive Cardiol (1999) 3.39
A controlled trial of an educational program to prevent low back injuries. N Engl J Med (1997) 3.33
The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA (1990) 2.89
Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56
The unfolded protein response: an intracellular signalling pathway with many surprising features. Trends Cell Biol (1998) 2.48
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst (1989) 2.31
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol (1995) 2.26
Chief complaint of fatigue: a prospective study. J Fam Pract (1990) 2.25
The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol (2003) 2.25
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs (1992) 2.22
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol (1992) 2.19
Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98. Vet Rec (2000) 2.17
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. Clin Cancer Res (2000) 2.14
Hippocampal system and declarative (relational) memory: summarizing the data from functional neuroimaging studies. Hippocampus (1999) 2.14
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
Effects of a physician communication intervention on patient care outcomes. J Gen Intern Med (1996) 2.06
Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer (1978) 2.04
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene (1997) 1.97
The efficacy of a semirigid ankle stabilizer to reduce acute ankle injuries in basketball. A randomized clinical study at West Point. Am J Sports Med (1994) 1.94
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol (1998) 1.91
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer (1975) 1.84
Do patient age and medical condition influence medical advice to stop smoking? Age Ageing (2000) 1.83
Benzodiazepine prescribing in a Sydney teaching hospital. Med J Aust (1996) 1.82
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. J Clin Oncol (1994) 1.76
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest (1991) 1.72
Preemployment drug screening. The epidemiologic issues. J Occup Med (1992) 1.70
How good are doctors at estimating children's weight? J Accid Emerg Med (1997) 1.69
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. J Clin Oncol (1994) 1.67
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
The experience and training of British general surgeons in trauma surgery for the abdomen, thorax and major vessels. Ann R Coll Surg Engl (2002) 1.62
Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer (1985) 1.61
Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59
Chromosomal assignment of a family of human oncogenes. Proc Natl Acad Sci U S A (1983) 1.53
Dose response evaluation of adriamycin in human neoplasia. Cancer (1977) 1.51
Preoperative radiotherapy for adenocarcinoma of the rectosigmoid. Cancer (1976) 1.50
Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol (1985) 1.50
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet (1983) 1.49
Long-term results with primary retroperitoneal tumors. Arch Surg (1989) 1.48
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. J Pharm Sci (1989) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Portable stove use is associated with lower lung cancer mortality risk in lifetime smoky coal users. Br J Cancer (2008) 1.47
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. Ann Intern Med (1988) 1.46
Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone. Arch Intern Med (1994) 1.43
Why patients consult and what happens when they do. BMJ (1991) 1.42
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Leukemia (2010) 1.42
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42
Some factors associated with mortality in perforated peptic ulcer: a case-control study. J Gastroenterol Hepatol (1996) 1.42
Types of patients in a psychiatric intensive care unit. Aust N Z J Psychiatry (2001) 1.42
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol (1996) 1.41
Phase II evaluation of adriamycin in human neoplasia. Cancer (1973) 1.40
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol (2002) 1.40
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon. Cancer J Sci Am (1998) 1.40
Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem (1992) 1.40
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study. J Clin Oncol (1990) 1.39
Workers' compensation cost shifting: an empirical study. Am J Ind Med (1991) 1.39
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group. Cancer Invest (1991) 1.39
Risk and severity of non-back occupational injuries after lumbar laminectomy for degenerative disc disease. Am J Ind Med (1991) 1.39
Colorectal cancer in young patients: characteristics and outcome. Am Surg (1994) 1.38
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res (1980) 1.38
Parasuicide assessment in the emergency department. Ir Med J (2005) 1.38
Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Cancer J Sci Am (2006) 1.38
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group. Cancer (1997) 1.38
Cancer of the colon. Ann Surg (1967) 1.37
Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol (1987) 1.33
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31
In differentiated CD4+ T cells, interleukin 4 production is cytokine-autonomous, whereas interferon gamma production is cytokine-dependent. Proc Natl Acad Sci U S A (1997) 1.31
Physical and nonphysical partner abuse and other risk factors for low birth weight among full term and preterm babies: a multiethnic case-control study. Am J Epidemiol (1999) 1.30
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Prognostic factors in multiple myeloma. Cancer (1975) 1.29
Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med (1996) 1.29
Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29
Presentation and treatment of annular pancreas in an adult population. Am J Gastroenterol (1995) 1.28
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28
Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group report. Cancer (1977) 1.27
Activation of nuclear factor kappaB in single living cells. Dependence of nuclear translocation and anti-apoptotic function on EGFPRELA concentration. J Biol Chem (1999) 1.27